Review





Similar Products

hybridoma against nucleolin  (Developmental Studies Hybridoma Bank)
94
Developmental Studies Hybridoma Bank hybridoma against nucleolin
Hybridoma Against Nucleolin, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hybridoma against nucleolin/product/Developmental Studies Hybridoma Bank
Average 94 stars, based on 1 article reviews
hybridoma against nucleolin - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
nucleolin polyclonal antibody  (Proteintech)
94
Proteintech nucleolin polyclonal antibody
Nucleolin Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleolin polyclonal antibody/product/Proteintech
Average 94 stars, based on 1 article reviews
nucleolin polyclonal antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
nucleolin antibody  (Proteintech)
94
Proteintech nucleolin antibody
Nucleolin Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleolin antibody/product/Proteintech
Average 94 stars, based on 1 article reviews
nucleolin antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
nucleolin ncl  (Proteintech)
94
Proteintech nucleolin ncl
Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
Nucleolin Ncl, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleolin ncl/product/Proteintech
Average 94 stars, based on 1 article reviews
nucleolin ncl - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti-nucleolin mouse monoclonal antibody  (Santa Cruz Biotechnology)
90
Santa Cruz Biotechnology anti-nucleolin mouse monoclonal antibody
Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
Anti Nucleolin Mouse Monoclonal Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-nucleolin mouse monoclonal antibody/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
anti-nucleolin mouse monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
alexa fluor 488-labeled nucleolin monoclonal antibody  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc alexa fluor 488-labeled nucleolin monoclonal antibody
Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
Alexa Fluor 488 Labeled Nucleolin Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alexa fluor 488-labeled nucleolin monoclonal antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
alexa fluor 488-labeled nucleolin monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
nucleolin antibody 14574t  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc nucleolin antibody 14574t
Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
Nucleolin Antibody 14574t, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nucleolin antibody 14574t/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
nucleolin antibody 14574t - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
alexa fluor® 488-labeled nucleolin monoclonal antibody  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc alexa fluor® 488-labeled nucleolin monoclonal antibody
Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
Alexa Fluor® 488 Labeled Nucleolin Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/alexa fluor® 488-labeled nucleolin monoclonal antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
alexa fluor® 488-labeled nucleolin monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti ncl  (Cell Signaling Technology Inc)
95
Cell Signaling Technology Inc anti ncl
Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and <t>nucleolin</t> expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, <t>NCL</t> and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.
Anti Ncl, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ncl/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti ncl - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and nucleolin expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, NCL and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.

Journal: World Journal of Hepatology

Article Title: Chromatin accessibility module identified by single-cell sequencing underlies the diagnosis and prognosis of hepatocellular carcinoma

doi: 10.4254/wjh.v17.i6.107329

Figure Lengend Snippet: Epigenetic coordination between malignant and stromal cells. A: Co-accessible chromatin peaks between tumor and non-tumor cells (log10 transformed counts); B: Ligand-receptor interactions initiated by malignant cells in tumor microenvironments, quantified via CellChat; C: A bar plot showing the log10 of co-accessible peaks number among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; D: A bar plot showing the number of ligand-receptor interactions when setting malignant cells as source among tumor cells and non-tumor cells across differentiated tumors and nondifferentiated tumors; E: Gene ontology enrichment for genes linked to malignant co-accessible regions. The score indicated normalized enrichment scores and q value denote Benjamini-Hochberg-adjusted P values; F: A circle network plot showing communication networks of the three common signaling pathways, Collagen, midkine (MDK) and peptidylprolyl isomerase A across differentiated tumors and nondifferentiated tumors. Line width indicates interaction strength; G: Expression of MDK pathway ligands (MDK, orange) and receptors (green) across differentiation states. Undifferentiated tumors exhibit upregulated MDK; H: MDK and nucleolin expression was lowest in well-differentiated samples grouped by Hoshida subtypes; I: Western blot of MDK, NCL and H3K27Ac expression in SNU449 cells transfected with 1 μmol/L A485 (CREB-binding protein/P300 inhibitor) for 48 hours. glyceraldehyde-3-phosphate dehydrogenaseserved as a loading control; J: Quantification of MDK, NCL and H3K27Ac levels normalized to glyceraldehyde-3-phosphate dehydrogenase ( n = 3). scRNA-seq: Single-cell RNA-sequencing; MK: Midkine related pathway; CypA: Peptidylprolyl isomerase A; MDK: Midkine; SDC: Syndecan; LRP: LDL Receptor Related Protein; NCL: Nucleolin; H3K27Ac: Histone 3 lysine 27 acetylation; CBP: CREB-binding protein; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.

Article Snippet: Gene expression of midkine (MDK) (1:1000; Proteintech #11009-1-AP) and nucleolin (NCL) (1:1000; Proteintech #83380-1-RR) was further identified in biological triplicates with statistical significance assessed by student’s t -test ( P < 0.05). siRNA transfection: siRNA was designed using the DharmaconTM siRNA Design Tool.

Techniques: Transformation Assay, Protein-Protein interactions, Expressing, Western Blot, Transfection, Binding Assay, Control, RNA Sequencing